Stock EVT EVOTEC SE
Add to a list
To use this feature you must be a member
Log inSign up

News Evotec SE

Equities

EVT

DE0005664809

Market Closed - Xetra
Other stock markets
 11:38:48 2024-05-13 am EDT 		After market 12:18:29 pm
9.97 EUR +4.73% Intraday chart for Evotec SE 9.94 -0.30%
May. 06 EVOTEC : Warburg Research reiterates its Buy rating ZD
May. 03 EVOTEC : RBC reiterates its Buy rating ZD

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQ
Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQ
Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQ
EVOTEC : Warburg Research reiterates its Buy rating
ZD
Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQ
DD: Evotec SE: Dr. Cord Dohrmann, Restricted shares granted as Short Term Variable Incentive (Bonus) for 2023 pursuant Evotec’s remuneration system.
EQ
Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQ
Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQ
Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQ
Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQ
EVOTEC : RBC reiterates its Buy rating
ZD
Evotec : Information on agenda item 4 “Appointment of the auditor, the Group auditor for the 2024 financial year and the auditor for the review of additional interim financial information”,
PU
Evotec : Remuneration report 2023 on agenda item 5,
PU
Evotec : Convening and Agenda of the Annual General Meeting,
PU
Evotec : Information pursuant to § 125 para. 1 AktG in conjunction with. §125 para. 5 AktG, Article 4 para. 1 as well as Table 3 of the Annex to the Implementing Regulation (EU) 2018/1212,
PU
Evotec : Revocation of proxy,
PU
Evotec : partner Kazia reports the successful completion of the EVT801 Phase 1 clinical trial in advanced cancer patients
PU
Evotec : CVs of the Supervisory Board candidates on agenda item 8,
PU
Evotec : Explanatory notes on the resolutionless item 1,
PU
Evotec : Explanation of shareholders' rights,
PU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. EVT Stock
  4. News Evotec SE
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW